Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by boazklinghornon Apr 29, 2023 10:06am
91 Views
Post# 35420693

RE:New Guy

RE:New Guy There is only one catalyst that can move the SP this year and that is a deal for the CoQ10 formulation. If that doesnt happen we will all be back here next year. Sigrun needs to generate revenue of at least 5 or 6 times what we are paying her in order for her to be a net positive to the company as her wages come right off the bottom line, same goes for new guy. There is nothing other than a transformative deal that would convince me to give Gilles another year at the helm of this company.
Given the set up with a real novel technology in the PGX and preexitsing relationships with some major corporations including Pepsi and Jand J we should be sitting on a mountain of profits by now instead we have a mouintain of excuses.
<< Previous
Bullboard Posts
Next >>